DA
MDT icon

Drake & Associates’s Medtronic MDT Stock Holding History

Drake & Associates’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$583K Sell
7,457
-5,394
-42% -$435K 0.1% 66
2026
Q1 		$1.11M Sell
12,851
-5,287
-29% -$506K 0.21% 43
2025
Q4 		$1.74M Sell
18,138
-9,780
-35% -$950K 0.35% 35
2025
Q3 		$2.52M Buy
+27,918
New +$2.57M 0.53% 32

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Drake & Associates's MDT Position: Q2 2026 in Review

Drake & Associates reduced its Medtronic (MDT) stake by 42% in Q2 2026, selling an estimated $435K and leaving 7,457 shares worth $583K. The position accounts for 0.1% of the portfolio, ranked #66.

Drake & Associates first reported a position in MDT in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.52M in Q3 2025. 2,123 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Drake & Associates held 7,457 shares of Medtronic worth $583K as of Q2 2026.
  • Drake & Associates sold 5,394 Medtronic shares in Q2 2026, an estimated $435K.
  • Medtronic made up 0.1% of Drake & Associates's portfolio in Q2 2026, its #66 holding.
  • Drake & Associates first reported a position in Medtronic in Q3 2025 and has held it in 4 quarters since.
  • Drake & Associates's Medtronic position peaked at $2.52M in Q3 2025.
  • 2,123 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Drake & Associates's 13F filing for Q2 2026, filed 10 Aug 2026.